Bayesian modeling and prediction of accrual in multi-regional clinical trials

被引:10
|
作者
Deng, Yi [1 ]
Zhang, Xiaoxi [2 ]
Long, Qi [1 ]
机构
[1] Emory Univ, Dept Biostat & Bioinformat, 1518 Clifton Rd NE, Atlanta, GA 30322 USA
[2] Pfizer Inc, New York, NY USA
关键词
Bayesian modeling; clinical trials; multi-regional trials; nonhomogeneous Poisson process; patient accrual; MULTICENTER TRIALS; EVENT TIMES; RECRUITMENT;
D O I
10.1177/0962280214557581
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
In multi-regional trials, the underlying overall and region-specific accrual rates often do not hold constant over time and different regions could have different start-up times, which combined with initial jump in accrual within each region often leads to a discontinuous overall accrual rate, and these issues associated with multi-regional trials have not been adequately investigated. In this paper, we clarify the implication of the multi-regional nature on modeling and prediction of accrual in clinical trials and investigate a Bayesian approach for accrual modeling and prediction, which models region-specific accrual using a nonhomogeneous Poisson process and allows the underlying Poisson rate in each region to vary over time. The proposed approach can accommodate staggered start-up times and different initial accrual rates across regions/centers. Our numerical studies show that the proposed method improves accuracy and precision of accrual prediction compared to existing methods including the nonhomogeneous Poisson process model that does not model region-specific accrual.
引用
收藏
页码:752 / 765
页数:14
相关论文
共 50 条
  • [1] Bayesian joint models for multi-regional clinical trials
    Bean, Nathan W.
    Ibrahim, Joseph G.
    Psioda, Matthew A.
    BIOSTATISTICS, 2023, 25 (03) : 852 - 866
  • [2] Bayesian design of multi-regional clinical trials with time-to-event endpoints
    Bean, Nathan William
    Ibrahim, Joseph George
    Psioda, Matthew Austin
    BIOMETRICS, 2023, 79 (04) : 3586 - 3598
  • [3] Multi-Regional Clinical Trials - What are the Challenges?
    Wang, Sue-Jane
    PHARMACEUTICAL STATISTICS, 2010, 9 (03) : 171 - 172
  • [4] On evaluation of consistency in multi-regional clinical trials
    Ying, Lisa
    Song, Fuyu
    Chow, Shein-Chung
    Zeng, Na
    Zheng, Jiayin
    Li, Xiaodong
    Henry, David
    Sethuraman, Venkat
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2018, 28 (05) : 840 - 856
  • [5] Stochastic modeling and prediction for accrual in clinical trials
    Zhang, Xiaoxi
    Long, Qi
    STATISTICS IN MEDICINE, 2010, 29 (06) : 649 - 658
  • [6] Bayesian accrual modeling and prediction in multicenter clinical trials with varying center activation times
    Liu, Junhao
    Wick, Jo
    Jiang, Yu
    Mayo, Matthew
    Gajewski, Byron
    PHARMACEUTICAL STATISTICS, 2020, 19 (05) : 692 - 709
  • [8] Influence Diagnostics of a Region of Interest in Multi-regional Clinical Trials
    Kuribayashi, Kazuhiko
    Cao, Charlie
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2023, 57 (02) : 220 - 226
  • [9] Influence Diagnostics of a Region of Interest in Multi-regional Clinical Trials
    Kazuhiko Kuribayashi
    Charlie Cao
    Therapeutic Innovation & Regulatory Science, 2023, 57 : 220 - 226
  • [10] Application of estimand framework to the design and analysis of multi-regional clinical trials
    Niu, Cuizhen
    Liang, Liwen
    Fu, Rong
    Zhong, Wenyan
    Wang, William W. B.
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2024,